In line with our results, Cooke et al. have shown an increased reactivity to agonist induced platelet stimulation (measured by P-selectin expression and platelet aggregometry) in patients with metastatic cancer of different origins [31]. Here, SELP is linked to metastatic malignant neoplasm.